Biotech Values

[DonShimoda]

There must be a lot of suckers who thought that changing the SAP in midstream was bullish.

I say welcome aboard and here's a bucket. Now, please start bailing me out of my position, lol.

fwiw, the company's epilepsy drug, CPP115, has potential but until they find a partner the value will remain unrealized. Until then the stock will be driven by CPP109, which is a coin flip. And now that the SAP has changed, the results will "be open to interpretation"....ugh. In hindsight, I should have initiated my position after the CPP109 results but before any partnership.